Zagreb, Croatia
NCT Number: NCT01384214
Effect of Botulinum Toxin Type A on Swallowing in Patients With Cervical Dystonia
The purpose of this study is to evaluate swallowing efficiency in patients with cervical dystonia following treatment with botulinum toxin Type A.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Diagnosed with cervical dystonia
- Successfully completed Allergan study MedAff BTX-0616 with 16 weeks since last botulinum toxin Type A injection
- In need of additional botulinum toxin Type A injections
Exclusion criteria
- Surgery or spinal cord stimulation for cervical dystonia
- Previous injections of phenol or alcohol for cervical dystonia
Treatment and study plan
Botulinum toxin type A
Biological750 U at Visit 1
Other names: Dysport®
Primary outcomes
-
Change from Baseline in Oropharyngeal Swallow Efficiency (OPSE)
Time frame: Baseline, Week 2
Secondary outcomes
-
Toronto Western Spasmodic Torticollis Scale (TWSTRS) Total Score
Time frame: Week 4
-
Physician Assessment of Cervical Dystonia Severity
Time frame: Week 4
-
Global Assessment of Benefit by Physician
Time frame: Week 4
-
Global Assessment of Benefit by Patient
Time frame: Week 4
-
Patient Visual Analog Assessment of Pain
Time frame: Week 4
Sponsors and collaborators
Lead sponsor
Allergan
Industry
Registry information
Official study title
Pilot Study of the Effect of Botulinum Toxin Type A Treatment on Swallowing in Patients With Cervical Dystonia
Important dates
- Study start
- 2008
- Primary completion
- 2009
- Study completion
- 2009
- First posted
- Jun 29, 2011
- Registry last updated
- Jun 29, 2011
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA
NCT01655862
Dyskinesias, Dystonia
Greenfield Park, Quebec, Canada
View Trial DetailsIs Home Positioning Time Associated With Torticollis Rate of Recovery?
NCT00347334
Dyskinesias, Dystonia
Beachwood, Ohio, United States
View Trial DetailsEffects of Botulinum Toxin in Cervical Dystonia
NCT01056861
Cervical Dystonia, Dyskinesias
Detroit, Michigan, United States
View Trial DetailsMDs on Botox Utility (MOBILITY)
NCT00535938
Blepharospasm, Cranial Nerve Diseases
Toronto, Ontario, Canada
View Trial Details